Glusod (Empagliflozin)

Glusod is indicated for the treatment of specific chronic conditions where glucose control and cardiovascular benefits are needed.

• Management of type 2 diabetes mellitus as an adjunct to diet and exercise.
• Reduction of cardiovascular death in adults with established heart failure.
• Improvement of glycemic control in patients with inadequate response to other antidiabetic agents.
• Potential use in combination therapy with other oral antihyperglycemic drugs.
• Support of renal protection in patients with diabetic kidney disease, as part of comprehensive care.

Empagliflozin may cause a range of side effects, most of which are mild and transient. Serious adverse events are less common but require medical attention.

Common

• Increased urinary frequency or volume.
• Genital mycotic infections (e.g., yeast infections).
• Mild dehydration or thirst.
• Lower limb edema.
• Mild nausea or abdominal discomfort.

Serious

• Ketoacidosis (euglycemic diabetic ketoacidosis).
• Acute kidney injury.
• Severe urinary tract infections.
• Hypotension leading to dizziness or fainting.
• Rare cases of severe hypersensitivity reactions.

Before starting Glusod, certain health considerations should be reviewed to ensure safe use.

• Assess renal function; avoid use in patients with severe renal impairment.
• Monitor blood pressure, especially in those prone to hypotension.
• Evaluate risk of ketoacidosis, particularly in low‑carbohydrate diets.
• Caution in patients with a history of genital or urinary infections.
• Discuss any planned surgeries or fasting periods with a healthcare provider.
• Review concomitant medications that may affect fluid balance or glucose levels.

Glusod can interact with several drug classes, influencing its efficacy or safety profile.

Avoid

• Loop diuretics combined with high doses of empagliflozin, which may increase risk of dehydration.
• Strong CYP2C8 inhibitors (e.g., gemfibrozil) that could raise empagliflozin plasma concentrations.

Use with caution

• Other antihyperglycemic agents, especially insulin, due to additive glucose‑lowering effects.
• Medications that raise potassium levels, such as ACE inhibitors or ARBs.
• NSAIDs, which may affect renal function when used together.
• Alcohol, as it can exacerbate hypotensive effects.
• Antimicrobial agents that predispose to fungal infections.